Elena Csernok

582 total citations
18 papers, 412 citations indexed

About

Elena Csernok is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Elena Csernok has authored 18 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Rheumatology and 9 papers in Immunology. Recurrent topics in Elena Csernok's work include Vasculitis and related conditions (15 papers), Urticaria and Related Conditions (5 papers) and Mast cells and histamine (3 papers). Elena Csernok is often cited by papers focused on Vasculitis and related conditions (15 papers), Urticaria and Related Conditions (5 papers) and Mast cells and histamine (3 papers). Elena Csernok collaborates with scholars based in Germany, United Kingdom and Finland. Elena Csernok's co-authors include Wolfgang L. Gross, W L Gross, A. Schnabel, Ulf Schönermarck, Hinrich P. Hansen, Guochun Wang, A Trabandt, Jörg Braun, Hilmar Lemke and Efstratios Tatsis and has published in prestigious journals such as The American Journal of Medicine, Annals of the Rheumatic Diseases and Thorax.

In The Last Decade

Elena Csernok

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Csernok Germany	11	326	176	148	113	51	18	412
Bill Paspaliaris Australia	7	422 1.3×	215 1.2×	145 1.0×	145 1.3×	134 2.6×	10	588
Alicia Rodríguez-Pla United States	10	261 0.8×	159 0.9×	122 0.8×	21 0.2×	36 0.7×	27	387
P Bini Italy	8	93 0.3×	153 0.9×	193 1.3×	51 0.5×	43 0.8×	11	428
Daina Selga Sweden	12	386 1.2×	134 0.8×	106 0.7×	98 0.9×	136 2.7×	18	458
Lorraine O’Neill Ireland	9	223 0.7×	175 1.0×	100 0.7×	19 0.2×	70 1.4×	16	321
Elisabeth A. Berg United States	7	474 1.5×	187 1.1×	289 2.0×	79 0.7×	115 2.3×	9	604
H Elling Denmark	12	322 1.0×	244 1.4×	77 0.5×	19 0.2×	105 2.1×	28	439
P Lesavre France	9	186 0.6×	124 0.7×	142 1.0×	82 0.7×	71 1.4×	29	392
Youri Chanseaud France	12	123 0.4×	92 0.5×	120 0.8×	38 0.3×	30 0.6×	13	379
H Schotte Germany	11	56 0.2×	184 1.0×	140 0.9×	47 0.4×	31 0.6×	19	349

Countries citing papers authored by Elena Csernok

Since Specialization

Citations

This map shows the geographic impact of Elena Csernok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Csernok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Csernok more than expected).

Fields of papers citing papers by Elena Csernok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Csernok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Csernok. The network helps show where Elena Csernok may publish in the future.

Co-authorship network of co-authors of Elena Csernok

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Csernok. A scholar is included among the top collaborators of Elena Csernok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Csernok. Elena Csernok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Csernok, Elena, et al.. (2018). FRI0650 The diagnostic value of the aeskulisa pr3 sensitive & aeskulisa mpo in the euvas-cohort. Annals of the Rheumatic Diseases. 77. 846–847.

Schönermarck, Ulf, Elena Csernok, & W L Gross. (2014). Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014. Nephrology Dialysis Transplantation. 30(suppl_1). i46–i52. 40 indexed citations

Holle, Julia U., et al.. (2013). Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis. Lara D. Veeken. 52(7). 1183–1189. 28 indexed citations

Metzler, Claudia, Elena Csernok, Wolfgang L. Gross, & Bernhard Hellmich. (2010). Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study.. PubMed. 28(1 Suppl 57). 24–30. 32 indexed citations

Csernok, Elena & W L Gross. (2000). Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects. Archives of Dermatological Research. 292(9). 427–436. 18 indexed citations

Müller, Antje, A Trabandt, Ulrike Seitzer, et al.. (2000). Localized Wegener's granulomatosis: predominance of CD26 and IFN‐γ expression. The Journal of Pathology. 192(1). 113–120. 1 indexed citations

Trabandt, A, et al.. (2000). Localized Wegener's granulomatosis: predominance of CD26 and IFN-? expression. The Journal of Pathology. 192(1). 113–120. 77 indexed citations

Csernok, Elena, et al.. (2000). Immunodiagnostic Aspects of Autoantibodies Against Myeloperoxidase. PubMed. 37(4). 180–185. 2 indexed citations

Schnabel, A., Elena Csernok, Jörg Braun, & W L Gross. (1999). Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax. 54(9). 771–778. 42 indexed citations

10.

Csernok, Elena, A Trabandt, Antje Müller, et al.. (1999). Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis & Rheumatism. 42(4). 742–742. 10 indexed citations

11.

Schmitt, Wilhelm H., et al.. (1998). Churg‐Strauss syndrome: Serum markers of lymphocyte activation and endothelial damage. Arthritis & Rheumatism. 41(3). 445–452. 12 indexed citations

12.

Schultz, Hendrik, et al.. (1997). Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA. Journal of Immunological Methods. 205(2). 127–133. 13 indexed citations

13.

Wang, Guochun, Hinrich P. Hansen, Efstratios Tatsis, et al.. (1997). High Plasma Levels of the Soluble Form of CD30 Activation Molecule Reflect Disease Activity in Patients with Wegener's Granulomatosis. The American Journal of Medicine. 102(6). 517–523. 63 indexed citations

14.

Csernok, Elena & Wolfgang L. Gross. (1995). [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].. PubMed. 54(1). 26–38. 3 indexed citations

15.

Nikkari, Simo, Raija Vainionpää, Paavo Toivanen, et al.. (1995). Reply. Arthritis & Rheumatism. 38(8). 1175–1175. 5 indexed citations

16.

Schnabel, A., et al.. (1993). Treatment of Wegener’s Granulomatosis with Intravenous Immunoglobulin. Advances in experimental medicine and biology. 336. 487–489. 28 indexed citations

17.

Schmitt, Wilhelm H., et al.. (1993). Autoantibodies Directed Against Lysozyme: A New Target Antigen for Anti-Neutrophil Cytoplasmic Antibodies (ANCA). Advances in experimental medicine and biology. 336. 267–272. 31 indexed citations

18.

Hermann, E, et al.. (1993). In Vitro Interactions of C-ANCA (Antibodies to Proteinase 3) with Human Endothelial Cells. Advances in experimental medicine and biology. 336. 109–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact